Comparative enantioseparations of pharmaceuticals in capillary electrochromatography on polysaccharidebased chiral stationary phases containing selectors with or without chlorinated derivatives

Electrophoresis

Volumn 31, Issue 19, 2010, Pages 3207-3216

  Hendrickx, Ans ^a   Mangelings, Debby ^a   Chankvetadze, Bezhan ^b   Heyden, Yvan Vander ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b TBILISI STATE UNIVERSITY   (Georgia)

Author keywords

CEC; Enantioseparations; Nonacidic compounds; Polysaccharide stationary phases

Indexed keywords

AMYLOSE; BENZOIC ACID DERIVATIVE; CARBAMIC ACID DERIVATIVE; CELLULOSE; CELLULOSE TRIS(4 CHLORO 3 METHYLPHENYLCARBAMATE); CELLULOSE TRIS(4-CHLORO-3-METHYLPHENYLCARBAMATE); DRUG; DRUG DERIVATIVE;

ARTICLE; CAPILLARY ELECTROCHROMATOGRAPHY; CHEMISTRY; COMPARATIVE STUDY; INSTRUMENTATION; ISOLATION AND PURIFICATION; METHODOLOGY; STEREOISOMERISM;

AMYLOSE; BENZOATES; CAPILLARY ELECTROCHROMATOGRAPHY; CELLULOSE; PHARMACEUTICAL PREPARATIONS; PHENYLCARBAMATES; STEREOISOMERISM;

EID: 79959206419     PISSN: 01730835     EISSN: 15222683     Source Type: Journal    
DOI: 10.1002/elps.201000249     Document Type: Article

References (44)

1. Francotte, E., Lindner W. (Eds.), Chirality in Drug Research, Wiley-VCH, Germany 2006.
2. Mc Conathy, J., Owens, M. J., J. Clin. Psychiatry 2003, 5, 70-73.
3. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human use; Draft Guidance on Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products (http://www. fda.gov/cder/guidance/1862dft.pdf).
4. US Food and Drug Administration. Guidances, Information Sheets, and Important Notices on Good Clinical Practice in FDA-Regulated Clinical Trials (http:// www.fda.gov/oc/gcp/guidance.html).
5. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human use; ICH Harmonised Tripartite Guideline for Good Clinical Practice: ICH Expert Working Group (http://www.ich.org/LOB/media/MEDIA482.pdf).
6. WHO Department of Essential Drugs and Other Medicines. Guidelines for Drug Donations 1999 (http:// whqlibdoc.who.int/hq/1999/WHO_EDM_PAR_99.4.pdf).
7. Ahuja, S., Dong, M. W. (Eds.), Handbook of Pharmaceutical Analysis by HPLC, Elsevier Academic Press, Amsterdam 2005.
8. Chankvetadze, B., Capillary Electrophoresis in Chiral Analysis, Wiley, Chichester 1997.
9. Girod, M., Chankvetadze, B., Okamoto, Y., Blaschke, G., J. Sep. Sci. 2001, 24, 27-34.
10. Fanali, S., Catarcini, P., Blaschke, G., Chankvetadze, B., Electrophoresis 2001, 22, 3131-3151.
11. Mangelings, D., Tanret, I., Matthijs, N., Maftouh, M., Massart, D. L., Vander Heyden, Y., Electrophoresis 2005, 26, 818-832.
12. Blanco, M., Valverde, I., Trends Anal. Chem. 2001, 22, 428-439.
13. Abe, I., Nagamatsu, D., Nakahara, T., Gerd, F., Chem. Lett. 2004, 33, 260-261.
14. Francotte, E., Jung, M., Chromatographia 1996, 42, 521-527.
15. Chankvetadze, L., Kartozia, I., Yamamoto, C., Chankvetadze, B., Blaschke, G., Okamoto, Y., Electrophoresis 2002, 23, 486-493.
16. Chankvetadze, B., Kartozia, I., Yamamoto, C., Okamoto, Y., Blaschke, G., J. Pharm. Biomed. Anal. 2003, 30, 1897-1906.
17. Mangelings, D., Hardies, N., Maftouh, M., Suteu, C., Massart, D. L., Vander Heyden, Y., Electrophoresis 2003, 20, 2567-2576.
18. Mangelings, D., Discry, J., Maftouh, M., Massart, D. L., Vander Heyden, Y., Electrophoresis 2005, 26, 3930-3941.
19. Matthijs, N., Perrin, C., Maftouh, M., Massart, D. L., Vander Heyden, Y., J. Chromatogr. A 2004, 1041, 119-133.
20. Perrin, C., Matthijs, N., Mangelings, D., Granier-Loyaux, C., Maftouh, M., Massart, D. L., Vander Heyden, Y., J. Chromatogr. A 2002, 966, 119-134.
21. Perrin, C., Vu, V. A., Matthijs, N., Maftouh, M., Massart, D. L., Vander Heyden, Y., J. Chromatogr. A 2002, 947, 69.
22. Matthijs, N., Vander Heyden, Y., Biomed. Chromatogr. 2006, 20, 696.
23. Matthijs, N., Van Hemelryck, S., Maftouh, M., Massart, D. L., Vander Heyden, Y., Anal. Chim. Acta 2004, 525, 247.
24. Matthijs, N., Maftouh, M., Vander Heyden, Y., J. Chromatogr. A 2006, 1111, 48.
25. Matthijs, N., Maftouh, M., Vander Heyden, Y., J. Sep. Sci. 2006, 29, 1353.
26. Mangelings, D., Maftouh, M., Massart, D. L., Vander Heyden, Y., LC-GC Eur. 2006, 19, 40-47.
27. Okamoto, Y., J. Polym. Sci. A Polym. Chem. 2009, 47, 1731-1739.
28. Tachibana, K., Ohnishi, A., J. Chromatogr. A 2001, 906, 127-154.
29. Girod, B., Chankvetadze, G., Blaschke, J., J. Chromatogr. A 2000, 887, 439-455.
30. Meyring, M., Chankvetadze, B., Blaschke, G., J. Chromatogr. A 2000, 876, 157-167.
31. Chankvetadze, L., Kartozia, I., Yamamoto, C., Chankvetadze, B., Blaschke, G., Okamoto, Y., J. Sep. Sci. 2002, 25, 653-660.
32. Kawamura, K., Otsuka, K., Terabe, S., J. Chromatogr. A 2001, 924, 251-257.
33. Chankvetadze, B., Yashima, E., Okamoto, Y., J. Chromatogr. A 1994, 670, 39-49.
34. Chankvetadze, B., Yashima, E., Okamoto, Y., J. Chromatogr. A 1995, 694, 101-109.
35. Chankvetadze, B., Chankvetadze, L., Sidamonidze, Sh., Yashima, E., Okamoto, Y., J. Pharm. Biomed. Anal. 1996, 14, 1295-1303.
36. Chankvetadze, B., Chankvetadze, L., Sidamonidze, Sh., Kasashima, E., Yashima, E., Okamoto, Y., J. Chromatogr. A 1997, 787, 67-77.
37. Ates, H., Mangelings, D., Vander Heyden, Y., J. Chromatogr. B 2008, 875, 57-64.
38. He, B. L., Shi, Y., Kleintop, B., Raglione, T., J. Chromatogr. B 2008, 875, 122-135.
39. Zhou, L., Antonucci, V., Biba, M., Gong, X., Ge, Z., J. Pharm. Biomed. Anal. 2010, 51, 153-157.
40. Zhou, L., Welch, C., Lee, C., Gong, X., Antonucci, V., Ge, Z., J. Pharm. Biomed. Anal. 2009, 49, 964-969.
41. Dossou, K. S. S., Chiap, P., Chankvetadze, B., Servais, A. C., Fillet, M., Crommen, J., J. Chromatogr. A 2009, 1216, 7450-7455.
42. West, C., Bouet, A., Gillaizeau, I., Coudert, G., Lafosse, M., Lesellier, E., Chirality 2010, 22, 242-251.
43. Fanali, S., D'Orazio, G., Lomsadze, K., Chankvetadze, B., J. Chromatogr. B 2008, 875, 296-303.
44. Fanali, S., D'Orazio, G., Lomsadze, K., Samakashvili, Sh., Chankvetadze, B., J. Chromatogr. A 2010, 1217, 1166-1174.